Project: Novel c-Met Targeted Molecular Imaging of Cancer with a multipurpose fluorescent imaging platform

Acronym	MetView (Reference Number: 113384)
Duration	01/10/2019 - 03/10/2022
Project Topic	MetView is a low-cost cancer diagnosis and surgery guidance solution that combines the novel EMI-137 optical imaging biomarker and a multifunctional imaging platform comprising of imaging and fluorescent detection hardware and control software. This advanced optical imaging solution will address the unmet need for regulatory approved tumour specific fluorescent imaging agents and supporting fluorescent imaging endoscopes, dramatically improving the imaging of precancerous and cancerous lesions.
Network	Eurostars 2
Call	Eurostars Cut–off 11

Project partner

Number	Name	Role	Country
1	Edinburgh Molecular Imaging Ltd.	Coordinator	United Kingdom
2	Quest Photonic Devices B.V.	Partner	Netherlands